Detail

Study ID: Alliance A091605

Title:

A Randomized Phase II Study of anti-PD1 antibody [MK-3475 (pembrolizumab)] alone versus anti-PD1 antibody plus Stereotactic Body Radiation therapy in advanced Merkel Cell Carcinoma

Location:
Bemidji Clinic, Bismarck Region, Fargo Region, Sioux Falls Region
Principal Investigator:
Preston Steen, MD,Preston Steen, MD,Preston Steen, MD,Preston Steen, MD
Disease:
Merkel Cell
Stage:
Phase II
Status:
Active - Open to Accrual